Le récepteur de somatostatine SST2 sensibilise les cellules cancéreuses pancréatiques a l'apoptose induite par les ligands de mort

Julie Guillermet‐Guibert(Centre National de la Recherche Scientifique), Corinne Bousquet(Centre National de la Recherche Scientifique), Lucien Pradayrol(Inserm), Philippe Rochaix(Inserm), Thierry Levade(Inserm), Louis Buscail(Tulane University), Nathalie Saint‐Laurent(Centre National de la Recherche Scientifique), C Susini, Olivier Cuvillier(Centre National de la Recherche Scientifique)
Unknown
February 29, 2008
Cited by 0

Related Papers

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251